M0241 Casiri and imdev repeat hm

Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency, subsequent repeat doses

Payer policies and prior authorization for M0241

Medicaid fee-for-service

  • KY: $750.00 (physician, non-facility), effective Jan 1, 2026
  • OH: $692.20 (provider_administered_drugs), effective Jul 1, 2023

From payers' published prior-auth lists, coverage policies and state Medicaid fee schedules, updated Oct 16, 2026. The role is what the policy's own code table or text says about the code. Not a guarantee of coverage or payment; verify with the payer. CPT® is a registered trademark of the American Medical Association.